Statins are drugs that can reduce one’s cholesterol level by blocking a substance the body needs to produce cholesterol. Statins may also aid the body to absorb and get rid of cholesterol that has developed in plaques on artery walls, thwarting further blockage in the blood vessels and heart attacks.
The significance of the statins may not be true after all as a new study conducted by a professor of neurology and the vice chair for research at Penn State College of Medicine, Xuemei Huang claims that cholesterol-lowering drugs may not be helpful as once perceived.
Huang stated, “We confirmed our previous finding that high total cholesterol and LDL cholesterol were associated with a lower risk of PD. Moreover, statin use over the course of the study did not protect against PD, and in fact appeared to increase PD risk in the long term. Although the analysis on statin use and PD was based on a fairly small number of PD cases, this preliminary data argues against the hypothesis that statins protect against PD.”
After whipping a careful examination Huang said that, “One possibility is that statin use can be a marker of people who have high cholesterol which itself may be associated with lower PD risk. This could explain why some studies have found an association between use of these medications and low incidence of PD. Most importantly, this purported benefit may not be seen over time.”
Huang stated, “Statins have been proven to be effective in the primary and secondary prevention of cardiovascular events and stroke. Although some have proposed that statins might be a ‘cure-all’ drug… this might be a case where what’s good for the heart isn’t good for the brain.”
It is of essence to ingest drugs that are connected with a specific organ. What is good for the heart may not be beneficial to the brain, since the medication might not come up with the same effects.
Huang quipped that statins have been very vital for preventing and treating vascular disease, but there is still a need for more research to understand if in some cases there is collateral damage. Huang added that she had discovered evidence that personalized medicine is better than an all-in-one medication.